Senores Pharmaceuticals Limited has informed the Exchange about appointment of Internal Auditors for FY 2025-26.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has appointed Sharp & Tannan Associates, Chartered Accountants (Firm Registration No. 109983W) as its Internal Auditor for the financial year 2025-26. The appointment was made by the Board of Directors on June 2, 2025, on the recommendation of the Audit Committee. Sharp & Tannan Associates is a well-established firm founded in 1934, headquartered in Mumbai, with branches across India and nine partners specializing in risk-based internal auditing. The board meeting commenced at 12:15 PM and concluded at 1:40 PM on the same day. This is a standard, routine annual appointment disclosed under SEBI Listing Regulations.
This is a routine compliance disclosure with no material impact on shareholders or the stock price. It reflects standard corporate governance practice with the appointment of a reputable, long-standing audit firm.